<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="486">
  <stage>Registered</stage>
  <submitdate>9/09/2005</submitdate>
  <approvaldate>16/09/2005</approvaldate>
  <actrnumber>ACTRN12605000417684</actrnumber>
  <trial_identification>
    <studytitle>A prospective randomised study comparing two techniques for establishing Continuous Femoral Nerve Blockade for postoperative analgesia following Total Knee Joint Replacement</studytitle>
    <scientifictitle>A prospective randomised study comparing a stimulating catheter (StimuCathTM Continuous Nerve Block Set, Arrow International) and a non-stimulating catheter (ContiplexR Tuohy Continuous Nerve Block Set, B. Braun) for establishing Continuous Femoral Nerve Blockade for postoperative analgesia following Total Knee Joint Replacement</scientifictitle>
    <utrn />
    <trialacronym>StimCath</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Postoperative analgesia for Total Knee Joint Replacement</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>This prospective randomised controlled study has been designed to examine if a stimulating catheter insertion (StimuCathTM Continuous Nerve Block Set, Arrow Internationl) technique improves the quality of Continuous Femoral Nerve Blockade following Total Knee Joint Replacement when compared to non-stimulating catheter insertion (ContiplexR Tuohy Continuous Nerve Block Set, B. Braun). Femoral nerve catheter insitu for no more than 24 hours.</interventions>
    <comparator>Non-stimulating nerve block</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Postoperative pain assessment</outcome>
      <timepoint>At 24 hours postop</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Postoperative morphine requirements</outcome>
      <timepoint>At 24 hours postop</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of the femoral nerve block.</outcome>
      <timepoint>Day 2 post op</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients undergoing primary Total Knee Joint Replacement.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Previous opioid dependence and/or chronic pain syndrome.Allergy or sensitivity to any study drugs including cycloosygenase inhibitors.BMI &gt; 38 and the inability to palpate landmarks.Inability to comprehend a VAS scale or use of patient controlled analgesia (PCA).Any contraindication to femoral nerve block.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelopes opened at the time of randomisation</concealment>
    <sequence>Computer software PC-Plan was used to generate random allocation in blocks.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3 / Phase 4</phase>
    <anticipatedstartdate>4/05/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>78</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Department of Anaesthesia, St Vincent's Hospital Melbourne</primarysponsorname>
    <primarysponsoraddress>Fitzroy</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>No secondary sponsor</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Michael Barrington</name>
      <address>Department of Anaesthesia
St Vincent's Hospital Melbourne
PO Box 2900
Fitzroy VIC 3065</address>
      <phone>+61 3 92882211</phone>
      <fax />
      <email>michael.BARRINGTON@svhm.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Simone Said</name>
      <address>Department of Anaesthesia
St Vincent's Hospital Melbourne
PO Box 2900
Fitzroy VIC 3065</address>
      <phone>+61 3 92884245</phone>
      <fax />
      <email>michael.BARRINGTON@svhm.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>